Can-Fite BioPharma Ltd. (CANF) Financials

CANF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 9.5 million 3.9 million
June 30, 2025 7.7 million 3.5 million
March 31, 2025 7.7 million 3.5 million
Dec. 31, 2024 9.1 million 3.7 million

CANF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 ? ?
June 30, 2025 -2.4 million 125500
March 31, 2025 -2.4 million 125500
Dec. 31, 2024 -1.8 million 84500

CANF Net Income

No data available :(

CANF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 - - 71000
June 30, 2025 6.5 million - 90000
March 31, 2025 6.5 million - 90000
Dec. 31, 2024 7.9 million - 104000

CANF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 1.7 million
June 30, 2025 11.4 million
March 31, 2025 11.4 million
Dec. 31, 2024 8.4 million

CANF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - - - -
June 30, 2025 500 1.5 million 1.0 million -
March 31, 2025 500 1.5 million 1.0 million -
Dec. 31, 2024 500 1.4 million 761000 -

CANF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 - -
June 30, 2025 101000 -
March 31, 2025 101000 -
Dec. 31, 2024 179000 -

CANF

Price: $3.16

52 week price:
2.83
23.40

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 29900

Market Capitalization: 1.7 million

Links: